Pricing Log in Create free account

MBody AI Ltd. (MBAI) vs Psychemedics Corporation (PMD)

MBody AI Ltd. and Psychemedics Corporation are both Diagnostics & Research companies. MBody AI Ltd. is the larger, with a market value of $47.4M against $15.7M — 3.0× the size. MBody AI Ltd. has the higher net margin (0.00% vs −9.45%) and the higher return on invested capital (0.00% vs −31.4%). Across the 14 metrics below, MBody AI Ltd. leads on 8 and Psychemedics Corporation on 6.

Valuation

Metric MBAI PMD Diagnostics & Research median
P/E n/m n/m 35.56
P/S n/m 0.80 4.37
P/B 0.61 3.05 3.06
Price to free cash flow n/m 19.46 35.76
EV/EBITDA n/m 77.29 24.35
EV/Sales n/m 0.74 5.51
Earnings yield (763.41%) (11.99%) (1.89%)
Free cash flow yield (565.34%) 5.14% (0.15%)

Profitability

Metric MBAI PMD Diagnostics & Research median
Gross margin 0.00% 36.07% 50.89%
Operating margin 0.00% (9.62%) (8.57%)
Net margin 0.00% (9.45%) (6.37%)
Free cash flow margin 0.00% 4.02% 0.00%
Return on equity 0.00% (31.54%) (2.92%)
Return on assets 0.00% (18.03%) (6.71%)
Return on invested capital 0.00% (31.42%) 0.00%

Growth

Metric MBAI PMD Diagnostics & Research median
Revenue growth (TTM) — (10.92%) 7.69%
EPS growth (last fiscal year) 115.35% 55.56% 25.92%
Revenue growth, 5-year CAGR — (12.18%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBAI PMD Diagnostics & Research median
Debt to equity 0.00 0.01 0.11
Current ratio 0.71 1.82 2.02
Net debt to EBITDA 0.09 (7.26) 0.70

Dividend

Metric MBAI PMD Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MBAI PMD Diagnostics & Research median
Market cap 47.41m 15.70m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack